Fred Whittlesey, Compensation Venture Group, SPCFred Whittlesey is the founder and Principal Consultant of Compensation Venture Group, SPC (CVG), a Seattle-area consulting firm specializing in compensation strategy, executive compensation, incentive compensation, equity-based compensation, and employee pay. CVG is a Washington Social Purpose Corporation. Fred also provides expert witness services for compensation-related litigation, is a Faculty member at Seattle Pacific University teaching graduate-level courses in total rewards systems as well as serving as a Faculty Adviser for student special projects, and is a writer for InvestorJunkie.com.
Amanda Benincasa is a Director and the East Coast Practice Leader with Aon Equity Services, the equity valuation and accounting group within Aon Rewards Solutions. Her background consists of valuation and technical accounting for equity, handling topics including employee stock options, restricted stock units, performance share awards, restricted stock awards, repurchases, IPOs, and an array of SEC reporting responsibilities (10Q/K, Proxy, Forms 4/5, etc.). She is an industry speaker, addressing topics related to equity valuation and accounting, and has written several articles surrounding the same topics. She serves on the Board of Directors of the NASPP Boston Chapter.
Randy Brown is a seasoned clinical operations executive with over 25 years of global drug and device development. Most recently he lead global clinical operations for Baxter Healthcare, an $11 billion dollar medical device company. Mr. Brown has lead several clinical development programs in over 30 countries resulting in several approvals. From 2015-2018 he served as the Vice President of Clinical Operations for an enteral feeding intolerance program, at Lyric Pharmaceuticals- a clinical stage pharmaceutical company, in critically ill patients. Randy has spent several years in leadership roles within clinical operations/program management for organizations such as DaVita, Anaclim/Spherix, and Eli Lilly. He has played key roles in several approvals including Xigris, Lipitor, and Viagra.
Aaron Shapiro is the Founder of Carver Edison. Carver Edison is a New York City-based financial technology company committed to helping public companies increase stock plan participation rates through its Cashless Participation™ technology and education platform, Carbon™. The company is backed by leading Fintech entrepreneurs and executives including Eli Broverman, co-founder of Betterment and Jeff Cruttenden, co-founder of Acorns. Aaron was the first investment professional at Edgehill Endowment Partners, a Connecticut based institutional investment firm co-founded by Ellen Shuman, an Institutional Investor Magazine Lifetime Achievement Award recipient. During Aaron’s tenure, Edgehill’s assets grew from $150 Million to over $4 Billion.